References | Genotype:COQ2 (NM_015697.8, NP_056512.5) | Phenotype | Effect of CoQ10 supplementation | Phenotype category |
---|---|---|---|---|
Diomedi-Camassei et al. [9] | c.[437G > A];[437G > A] p.[(Ser146Asn)];[(Ser146Asn)] | Acute renal failure, epileptic encephalopathy, hypotonia; died at 6 months | N/A | Severe multisystem |
Mollet et al. [12] | c.[1197delT];[1197delT] p.[(Asn401Ilefs*15)];[(Asn401 Ilefs*15)] | Neurological distress at birth; liver failure and nephrotic syndrome at 2Â days; died at day 12 from multi-organ failure | N/A | Severe multisystem |
Jakobs et al. [11] | c.[905C > T];[905C > T] p.[(Ala302Val)];[(Ala302Val)] | Dizygotic twins; Premature birth, feeding problems, generalized edema, seizures, apnea; retinopathy of prematurity in one twin; infantile death | N/A | Severe multisystem |
Scalais et al. [13] | c.[326G > A];[326G > A] p.[(Ser109Asn)];[(Ser109Asn)] | Myoclonic seizures, HCM, hypotonia, nystagmus (10 weeks);nephrotic syndrome (4 mo); died at 5 months | No improvement and continued deterioration | Severe multisystem |
Dinwiddie et al. [8] | c.437G > A(;)1159C > T p.(Ser146Asn)(;)(Arg387Ter) Additional c.3754C > A variant in the MT-ND1 gene | Neonatal diabetes, HCM, cardiomegaly, metabolic acidosis, encephalopathy, chronic renal tubular disease, respiratory failure, died at 2 months | N/A | Severe multisystem |
Desbats et al. [7] | c.[545 T > G];[545 T > G] p.[(Met182Arg)];[(Met182Arg)] | Lactic acidosis, proteinuria, hepatic insufficiency, dilation of left ventricle, worsening neurological condition, died at 23 h | N/A | Severe multisystem |
Eroglu et al. [10] | c.[437G > A];[437G > A] p.[(Ser146Asn)];[(Ser146Asn)] | Index case in family; neonatal diabetes, glomerular proteinuria, seizures, encephalopathy, hypotonia, electroretinography showed no response, death at 4.5 months | No improvement of renal or neurological symptoms | Severe multisystem |
Eroglu et al. [10] | c.[437G > A];[437G > A] p.[(Ser146Asn)];[(Ser146Asn)] | Affected sibling; neonatal diabetes, proteinuria, mild metabolic acidosis, seizures, kidney failure, died due to multi-organ failure at 31 months | Normalization of glucose, lactate levels; neurological deterioration with encephalopathy and refractory seizures; deterioration of kidney function | Severe multisystem |
Eroglu et al. [10] | c.[437G > A];[437G > A] p.[(Ser146Asn)];[(Ser146Asn)] | Index case in family; vomiting, proteinuria, nephrotic syndrome, refractory seizures, died at 6 months | N/A | Severe multisystem |
Eroglu et al. [10] | c.[437G > A];[437G > A] p.[(Ser146Asn)];[(Ser146Asn)] | Affected sibling; neonatal diabetes, proteinuria, seizures, diffuse cerebral atrophy; died at 14 months | Proteinuria improved; continued neurological deterioration | Severe multisystem |
Xu et al. [23] | c.[518G > A];[973A > G] p.[(Arg173His)];[(Thr325Ala)] | Edema, mild motor delay, moderate speech delay, nephrotic syndrome (11 months) | Edema resolved; improved kidney and motor development | NS + neurological symptoms |
Quinzii et al. [19], Salviati et al. [20], Diomedi-Camassei et al. [9], Lopez-Martin [16], Montini et al. [18] | c.[890A > G];[890A > G] p.[(Tyr297Cys)];[(Tyr297Cys)] | Index case in family; epileptic encephalopathy, hypotonia, mild psychomotor delay, optic atrophy, nephropathy, rod-cone retinopathy (11 mo), kidney transplant (3 years) | Drastic improvement in neurological manifestations; no improvement in renal dysfunction | NS + neurological symptoms + RP |
Quinzii et al. [19], Salviati et al. [20], Diomedi-Camassei et al. [9], Lopez-Martin [16], Montini et al. [18] | c.[890A > G];[890A > G] p.[(Tyr297Cys)];[(Tyr297Cys)] | Sister affected with only nephrotic syndrome (12 mo); no extra-renal involvement | Resolution of nephrotic syndrome | Isolated NS |
Diomedi-Camassei et al. [9] | c.[590G > A];[683A > G] p.[(Arg197His)];[(Asn228Ser)] | Nephrotic syndrome (onset at 18 mo); no extrarenal involvement | Neurological examination continued to be normal after 8-mo of follow up | Isolated NS |
McCarthy et al. [17] | c.[683A > G];[701delT] p.[(Asn228Ser)];[(Leu234Argfs*14)] | Nephrosis, renal failure (2 years) | N/A | Isolated NS |
Bezdicka et al. [14] | c.[683A > G];[683A > G] p.[(Asn228Ser)];[(Asn228Ser)] | Two affected siblings; nephrotic syndrome (3 years) | Kidney function improved in sibling; no supplementation in index case | Isolated NS |
Starr et al. [21] | c.[973A > G];[1159C > T] p.[(Thr325Ala)];[(Arg387Ter)] | Nephrotic syndrome (9 months) | Nephrotic syndrome resolved; continued proteinuria | Isolated NS |
Starr et al. [21] | c.[176dupT];[683A > G] p.[(Ala69Argfs*33)]; [(Asn228Ser)] | Nephrotic syndrome (2 years) | Nephrotic syndrome resolved; continued proteinuria | Isolated NS |
Wu et al. [22] | c.[832 T > C];[832 T > C] p.[(Cys278Arg)];[(Cys278Arg)] Also homozygous c.1213 + 1G > A variant in ARSB gene | Nephrotic syndrome, died (6 mo); no extrarenal involvement | N/A | Isolated NS |
Starr et al. [21] | c.[683A > G];[881C > T] p.[(Asn228Ser)];[(Thr294Ile)] | Nephrotic syndrome (10 years) | Nephrotic syndrome not resolved, progressed to ESRD | Juvenile-onset NS |
Gigante et al. [15] | c.[1169G > C];[1169G > C] p.[(Gly390Ala)];[(Gly390Ala)] | Index case in family with juvenile onset nephrotic syndrome and myoclonic epilepsy (16 years); affected cousin also with juvenile onset nephrotic syndrome (16 years), and headaches associated with phono-and photophobia | N/A | Juvenile-onset NS + neurological symptoms |
c.[382A > G];[382A > G] p.[(Met128Val)];[(Met128Val)] Additionally homozygous p.(Val393Ala) variant in COQ2 also detected | Index case in family; multi-system atrophy (onset 68 years), RP (diagnosed at 33 years) | N/A | MSA + RP | |
c.[382A > G];[382A > G] p.[(Met128Val)];[(Met128Val)] Additionally homozygous p.(Val393Ala) variant in COQ2 also detected | Affected sibling; multi-system atrophy (onset 62 years),RP(diagnosed at 51 years) | N/A | MSA + RP | |
Current study | c.[288dupC];[376C > G] p.[(Ala97Argfs*56)]; [(Arg126Gly)] | Three affected siblings with renal abnormalities and RP | No improvement in ERG function | NS + RP |